摘要
To develop cancer electrochemical treatment (ECT) in the United States, we have conducted basic studies and started a Phase I clinical trial. Our in vivo preliminary results indicate that ECT is effective on RIF-1 mouse tumor and rat fibrosarcomas. In the in vitro study ECT clearly demonstrated dose-dependent human oral carcinoma KB cell growth inhibition by colony-forming assay. We have started an animal study to resolve the ECT methodological problems for rat breast cancer. Meanwhile, we began a clinical trial treating patients with recurrent superficial measurable malignant tumors. Our goal is to make ECT a useful alternative method for treating localized tumors.
原文 | 英語 |
---|---|
主出版物標題 | Proceedings of the International Conference on Bioelectromagnetism |
發行者 | IEEE |
頁面 | 19-20 |
頁數 | 2 |
出版狀態 | 已發佈 - 1998 |
對外發佈 | 是 |
事件 | Proceedings of the 1998 2nd International Conference on Bioelectromagnetism - Melbourne, Australia 持續時間: 2月 15 1998 → 2月 18 1998 |
其他
其他 | Proceedings of the 1998 2nd International Conference on Bioelectromagnetism |
---|---|
城市 | Melbourne, Australia |
期間 | 2/15/98 → 2/18/98 |
ASJC Scopus subject areas
- 工程 (全部)